Log inSign up
AAOIFI No. 21 screening

Is CANF halal?

Can-Fite Biopharma Ltd

Not halal

Can-Fite Biopharma Ltd did not pass AAOIFI screening. The failed check is shown below.

Checked: 15 October 2026

Exchange

AMEX

Price

1.76

Day

-4.86%

Market cap

$5.8M

Industry

Biotechnology

Sector

Healthcare

What the company does

Can-Fite BioPharma (Israel) is testing namodenoson (liver cancer, fatty liver) and piclidenoson (psoriasis) in clinical trials. Revenue is negligible (licence advances).

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ current market cap $5.81M = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $8.54M ÷ current market cap $5.81M = 147.0%

    147.0%

    Fail

  • Non-compliant income / total revenue

    limit 5%

    Interest income $284K ÷ annual revenue $405K (2025) = 70.1%

    70.1%

    Fail

Figures from the company's filings (2025-12-31), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.